Literature DB >> 24402575

Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines.

Vanita Vanas1, Elsa Mühlbacher, Rosana Kral, Hedwig Sutterlüty-Fall.   

Abstract

Sprouty proteins are modulators of mitogen-induced signal transduction processes and therefore can influence the process of cancerogenesis. In particular, Sprouty2 has been shown to have an important role in cancer development of many tumor entities including breast cancer. In this report, we investigated the role of Sprouty4 in breast cancer-derived cell lines. We have found that ectopic Sprouty4 expression inhibits cell proliferation of breast cancer cell lines independently of their endogenous expression levels. Corroborating Sprouty4 downregulation causes accelerated growth. Furthermore, we demonstrate that an increase in Sprouty4 content interferes with serum-induced activation of mitogen-activated protein kinase pathway. Additionally, Sprouty4 expression negatively influences cell migration. These data suggest that Sprouty4 is a possible candidate for a tumor suppressor in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402575     DOI: 10.1007/s13277-013-1587-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

1.  Sprouty, an intracellular inhibitor of Ras signaling.

Authors:  T Casci; J Vinós; M Freeman
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

2.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

Review 3.  Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling.

Authors:  Jacqueline M Mason; Debra J Morrison; M Albert Basson; Jonathan D Licht
Journal:  Trends Cell Biol       Date:  2005-12-07       Impact factor: 20.808

4.  The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation.

Authors:  Francis Edwin; Rakesh Singh; Raelene Endersby; Suzanne J Baker; Tarun B Patel
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

5.  In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffected.

Authors:  Rosana Maria Kral; Christoph-Erik Mayer; Vanita Vanas; Andrea Gsur; Hedwig Sutterlüty-Fall
Journal:  Cell Biochem Funct       Date:  2013-04-24       Impact factor: 3.685

6.  Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf.

Authors:  Permeen Yusoff; Dieu-Hung Lao; Siew Hwa Ong; Esther Sook Miin Wong; Jormay Lim; Ting Ling Lo; Hwei Fen Leong; Chee Wai Fong; Graeme R Guy
Journal:  J Biol Chem       Date:  2001-11-06       Impact factor: 5.157

7.  Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia.

Authors:  Takaharu Taketomi; Daigo Yoshiga; Koji Taniguchi; Takashi Kobayashi; Atsushi Nonami; Reiko Kato; Mika Sasaki; Atsuo Sasaki; Hitoshi Ishibashi; Maiko Moriyama; Kei-ichiro Nakamura; Junji Nishimura; Akihiko Yoshimura
Journal:  Nat Neurosci       Date:  2005-07       Impact factor: 24.884

8.  Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.

Authors:  Atsuo Sasaki; Takaharu Taketomi; Reiko Kato; Kazuko Saeki; Atsushi Nonami; Mika Sasaki; Masamitsu Kuriyama; Naoaki Saito; Masabumi Shibuya; Akihiko Yoshimura
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

9.  Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction.

Authors:  M Albert Basson; Simge Akbulut; Judy Watson-Johnson; Ruth Simon; Thomas J Carroll; Reena Shakya; Isabelle Gross; Gail R Martin; Thomas Lufkin; Andrew P McMahon; Patricia D Wilson; Frank D Costantini; Ivor J Mason; Jonathan D Licht
Journal:  Dev Cell       Date:  2005-02       Impact factor: 12.270

10.  Diverse somatic mutation patterns and pathway alterations in human cancers.

Authors:  Zhengyan Kan; Bijay S Jaiswal; Jeremy Stinson; Vasantharajan Janakiraman; Deepali Bhatt; Howard M Stern; Peng Yue; Peter M Haverty; Richard Bourgon; Jianbiao Zheng; Martin Moorhead; Subhra Chaudhuri; Lynn P Tomsho; Brock A Peters; Kanan Pujara; Shaun Cordes; David P Davis; Victoria E H Carlton; Wenlin Yuan; Li Li; Weiru Wang; Charles Eigenbrot; Joshua S Kaminker; David A Eberhard; Paul Waring; Stephan C Schuster; Zora Modrusan; Zemin Zhang; David Stokoe; Frederic J de Sauvage; Malek Faham; Somasekar Seshagiri
Journal:  Nature       Date:  2010-07-28       Impact factor: 49.962

View more
  13 in total

1.  Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells.

Authors:  Angelina Doriguzzi; Jihen Salhi; Hedwig Sutterlüty-Fall
Journal:  Oncol Lett       Date:  2016-09-30       Impact factor: 2.967

2.  The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma.

Authors:  Yanqiang Wang; Huiling He; Sandya Liyanarachchi; Luke K Genutis; Wei Li; Lianbo Yu; John E Phay; Rulong Shen; Pamela Brock; Albert de la Chapelle
Journal:  Genet Med       Date:  2018-01-04       Impact factor: 8.822

3.  Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer.

Authors:  Abdullah Al Emran; Diego M Marzese; Dinoop R Menon; Heinz Hammerlindl; Farzana Ahmed; Erika Richtig; Pascal Duijf; Dave Sb Hoon; Helmut Schaider
Journal:  Epigenomics       Date:  2019-05-09       Impact factor: 4.778

4.  Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas.

Authors:  Barbara Klotz; Susanne Kneitz; Yuan Lu; William Boswell; John Postlethwait; Wesley Warren; Ronald B Walter; Manfred Schartl
Journal:  G3 (Bethesda)       Date:  2019-07-09       Impact factor: 3.154

5.  The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; Anahid Ehteda; Ai-Qun Wei; David Lawson Morris
Journal:  J Ovarian Res       Date:  2014-06-08       Impact factor: 4.234

Review 6.  The developing story of Sprouty and cancer.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; David Lawson Morris
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells.

Authors:  Hongyu Jing; Lucy Liaw; Robert Friesel; Calvin Vary; Shucheng Hua; Xuehui Yang
Journal:  Cancer Cell Int       Date:  2016-03-11       Impact factor: 5.722

8.  MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.

Authors:  Vanita Vanas; Barbara Haigl; Verena Stockhammer; Hedwig Sutterlüty-Fall
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

9.  H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma.

Authors:  Erbao Zhang; Liang Han; Dandan Yin; Xuezhi He; Linzhi Hong; Xinxin Si; Mantang Qiu; Tongpeng Xu; Wei De; Lin Xu; Yongqian Shu; Jinfei Chen
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

10.  MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4.

Authors:  Yifu Tian; Xiaodan Fu; Qingling Li; Ying Wang; Dan Fan; Qin Zhou; Weilu Kuang; Liangfang Shen
Journal:  Mol Med Rep       Date:  2018-10-22       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.